Daley S Morera

5PUBLICATIONS
7CO-AUTHORS
Biological physicsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Preventative health carePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 20, 2026
Primary Indolent Acute Promyelocytic Leukemia.

Breanne Wolfenbarger, Daley Morera, Brandol Wolfenbarger

|Jun 08, 2021
RAD51AP1 Loss Attenuates Colorectal Cancer Stem Cell Renewal and Sensitizes to Chemotherapy.

Allison E Bridges, Sabarish Ramachandran, Kavin Tamizhmani

|May 25, 2021
HYAL4-V1/Chondroitinase (Chase) Drives Gemcitabine Resistance and Predicts Chemotherapy Failure in Patients with Bladder Cancer.

Sarrah L Hasanali, Daley S Morera, Ronny R Racine

|Jul 16, 2020
<i>RAD51AP1</i> Deficiency Reduces Tumor Growth by Targeting Stem Cell Self-Renewal.

Allison E Bridges, Sabarish Ramachandran, Rajneesh Pathania

|Feb 26, 2020
A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder Cancer.

Vinata B Lokeshwar, Daley S Morera, Sarrah L Hasanali

Pageof 1

Frequent Collaborators

3 joint publications

Sarrah L Hasanali

3 joint publications

Vinata B Lokeshwar

2 joint publications

Nagendra Singh

2 joint publications

Hasan Korkaya